Search

A study conducted at Kameda Medical Center in Japan evaluated the use of deep learning models to predict the Nugent score for diagnosing bacterial vaginosis. The models demonstrated high accuracy levels, outperforming the average accuracy of laboratory technicians. This research suggests that deep learning models have the potential to standardize the diagnosis of bacterial vaginosis and reduce observer variability, especially in settings with limited access to experienced personnel. The study highlights the importance of accurate and consistent diagnosis of bacterial vaginosis, a global health issue affecting women. [Extracted from the article]

Researchers from St. Paul's Hospital Millennium Medical College published a study on two cases of postpartum vaginal stenosis, a rare obstetric complication. The cases involved Ethiopian women who underwent successful vaginal reconstruction after experiencing symptoms such as foul-smelling discharge and amenorrhea. The research concluded that adhesion excision with regular vaginal dilation is the recommended management for postpartum vaginal stenosis. The study was published in the Journal of Medical Case Reports and can be accessed for free online. [Extracted from the article]

A study conducted at the All India Institute of Medical Sciences (AIIMS) in West Bengal, India, explored the relationship between menstrual hygiene practices and bacterial vaginosis. The research found that poor menstrual hygiene practices were strongly associated with bacterial vaginosis, with a prevalence of 13% among symptomatic patients. Factors such as using clothes as absorbents, decreased frequency of bathing, and unsatisfactory sanitation of latrines were linked to an increased risk of developing bacterial vaginosis. The study highlights the importance of proper menstrual hygiene management in preventing infections like bacterial vaginosis. [Extracted from the article]

A recent study conducted at Rush University Medical Center focused on bacterial vaginosis (BV), a common reason for gynecological visits among women. The study aimed to validate and compare a molecular BV testing method to traditional Gram stained BV screens, showing promising results with high accuracy and precision. The research suggests that molecular testing may be a more cost-effective and efficient option for BV detection in clinical settings. For more information, the study "Clinical Validation and Comparison of Bacterial Vaginosis Detection" can be accessed in the American Journal of Clinical Pathology. [Extracted from the article]

Ainos Inc. has been issued a patent for a gas detection system for gynecological disease detection and a detection method using the same. The system aims to provide contactless detection of analytes from the female vagina, offering rapid detection results. The invention addresses the discomfort associated with traditional diagnostic methods for gynecological diseases, providing a more efficient and less invasive approach to detection and diagnosis. [Extracted from the article]

A study conducted at the Post Graduate Institute of Medical Sciences in Haryana, India, aimed to estimate the prevalence of pathological vaginal discharge (VD) in pregnant women and its impact on fetomaternal outcomes. The study found that 39.33% of enrolled women had pathological VD, with candidiasis, bacterial vaginosis, aerobic vaginitis, and trichomoniasis being the main etiologies. These infections were significantly associated with pre-term delivery, pre-term pre-labor rupture of membranes, prematurity, and low birth weight neonates requiring neonatal intensive care unit care. The researchers suggest that routine screening for pathological VD should be introduced into standard antenatal care for all pregnant women. [Extracted from the article]

A recent study conducted at Chirayu Medical College and Hospital in Bhopal, India, aimed to assess the awareness among female healthcare students regarding the physiological nature of vaginal discharge. The study included medical, paramedical, and nursing students, with a total of 246 participants. The results showed that medical students had the highest awareness and knowledge about vaginal discharge, followed by paramedical and nursing students. Interestingly, nursing students were found to consult doctors the most, while medical students consulted the least. However, the attitudes towards vaginal discharge were similar across all groups. [Extracted from the article]

A recent study conducted at the Post Graduate Institute in Haryana, India, focused on cervical fibroids, a rare condition that accounts for only 1-2% of cases. The study analyzed 24 cases of cervical fibroids and found that the most common symptoms were vaginal bleeding and urinary symptoms. The research also highlighted the challenges in diagnosing and treating central and supravaginal fibroids. The study concluded that proper pre-operative assessment is crucial for determining the appropriate treatment modality. [Extracted from the article]

A study conducted by the Kerman University of Medical Sciences in Iran examined the effectiveness of a herbal vaginal product called Cymbopogon olivieri in treating bacterial vaginosis, the most common vaginal infection in reproductive-age women. The study involved 90 women who were randomly divided into two groups, one receiving Cymbopogon olivieri and the other receiving metronidazole. The results showed that both treatments significantly reduced symptoms such as burning, itching, malodor, abnormal vaginal discharge, pH, clue cell, and positive whiff test. The study concluded that Cymbopogon olivieri is a suitable option for treating bacterial vaginosis. [Extracted from the article]

A clinical trial, NCT06530186, is being conducted to evaluate a postcoital sponge called Livi, developed by LiviWell, which is designed to absorb semen and reduce symptoms of postcoital vaginal microbiome disruption such as vaginal odor and discharge. The study aims to validate user needs requirements for the device, assess changes in vaginal pH, and evaluate symptoms of vaginal odor, discharge, and discomfort. The device is intended to prevent vaginal infections, vaginal discharge, vaginosis, and sexual dysfunction. The trial is not yet recruiting and will enroll 1000 sexually-active women in the United States. [Extracted from the article]

A recent study conducted at the University of Airlangga in Surabaya, Indonesia, aimed to determine the incidence and determinants of bacterial vaginosis (BV) in the sexually transmitted infection (STI) division of the Dermatovenereology Department at Dr. Soetomo Hospital. The study included 56 patients and found that the use of intrauterine devices (IUDs) and the number of sexual partners were significant determinants of BV incidence. The research emphasizes the importance of addressing these risk factors to prevent BV, which is the most common cause of abnormal vaginal discharge among women who can have children. [Extracted from the article]

A patent application has been published for a wearable device designed to control leakages from the perineum region. The device, developed by Nicholas Irwin and Mark Polyak, applies pressure to the openings in the perineum to prevent or reduce fluid or discharge leakages. It can be used for urinary incontinence, fecal incontinence, and vaginal disorders. The device is comfortable, easy to use, and not visible under clothing. It includes retraction mechanisms connected by a slider assembly, with a disposable absorbent member attached. The device is adjustable to different body shapes and sizes and allows for voluntary urination and easy replacement of the absorbent member. [Extracted from the article]

A clinical trial, NCT06453200, is currently underway in the Russian Federation to investigate the effectiveness of Bovhyaluronidase Azoximer in destroying biofilms in the urogenital tract of patients with recurrent bacterial vaginosis (BV). BV is a common condition that affects a significant percentage of women of reproductive age and is characterized by the presence of opportunistic microorganisms. Biofilms, particularly Gardnerella vaginalis, contribute to the persistence and resistance of BV to treatment. The study aims to determine if Bovhyaluronidase Azoximer can improve the effectiveness of antibacterial therapy and reduce the recurrence of BV. The study is recruiting 100 women between the ages of 18 and 45 and is comparing the efficacy of two treatments: Longidaza, a vaginal suppository, and Metronidazole, an oral tablet. The study is expected to be completed by June 2026 and is being conducted by the I.M. Sechenov First Moscow State Medical University. [Extracted from the article]

A new study conducted by researchers at Tehran University of Medical Sciences explores the prevalence of vaginal complications in patients who have undergone hematopoietic stem cell transplantation for the treatment of certain cancers. The study found that 49.1% of patients experienced vaginal symptoms, with 25.5% experiencing vulvar involvement. Reduced vaginal discharge and vaginal tightness were identified as significant predictors of other organ symptoms. The findings highlight the importance of addressing vaginal complications in transplant patients to improve their overall quality of life. [Extracted from the article]

A recent study from St. Thomas University provides new data on bacterial vaginosis, a common health problem affecting millions of women worldwide. Bacterial vaginosis is characterized by an imbalance in vaginal bacterial flora, with a reduction in Lactobacilli and a predominance of Gardnerella vaginalis and other anaerobic bacteria. Approximately 75% of women who undergo gynecological consultations have some alterations in their vaginal flora, and between 10% and 31% of these women are diagnosed with bacterial vaginosis. The condition is associated with symptoms such as abundant and malodorous vaginal discharge, itching, dysuria, and dyspareunia. In healthy women, vaginal fluid has a pH of 4.5 and is mainly composed of lactic acid, while women with bacterial vaginosis have higher levels of amines produced by G. vaginalis, which contribute to the foul odor associated with the condition. The study identified specific amines, including isobutylamine, 2-phenylethanamine, putrescine, cadaverine, and 4-(2-aminoethyl) phenol, as responsible for the foul odor. The research also explored the relationship between hygienic vulvo-vaginal habits, contraceptive use, and bacterial vaginosis. For more information, readers can refer to the journal article published in ARS Medica. [Extracted from the article]

A study conducted in Maputo, Mozambique examined the prevalence of sexually transmitted infections (STIs) and HIV-1/2 in women with urogenital complaints. The study found a high prevalence of chlamydia, trichomoniasis, and HIV-1/2 in women of childbearing age. However, the syndromic management of vaginal discharge, which is currently used for diagnosis and treatment, showed low accuracy in detecting STIs, resulting in under-treatment of positive cases and over-treatment of women who were negative for STIs. The researchers concluded that etiological diagnosis is crucial for effective management of STIs in both symptomatic and asymptomatic women. [Extracted from the article]

A recent study conducted at the Nepalese Army Institute of Health Sciences in Kathmandu, Nepal, aimed to determine the prevalence of infective vaginal discharge among women of reproductive age in a primary care center. The study found that out of 138 patients, 30.43% had infective vaginal discharge, with bacterial vaginosis being the most common condition (52.38%), followed by Candida (30.95%) and Trichomonas (16.66%). The researchers concluded that the prevalence of infective vaginal discharge in this setting was lower compared to other similar studies. For more information, readers can refer to the Journal of Nepal Medical Association. [Extracted from the article]

A recent study conducted at the University of Pretoria in South Africa examined the treatment outcomes of vaginal discharge syndrome (VDS) in women in Windhoek, Namibia. The study found that treatment failure after syndromic management of VDS is common in resource-constrained settings. The main pathogen in VDS was Candida albicans, with fluconazole resistance detected in some isolates. The study recommends access to diagnostic testing, including fungal culture and susceptibility testing, to improve treatment outcomes. [Extracted from the article]

A patent has been issued for vaginal care compositions and methods of improving vaginal health. The patent describes a vaginal care composition that restores pH balance, reduces vaginal dryness, irritation, dyspareunia, post-coital bleeding, infections, vaginal and pelvic pain, and increases vaginal lubrication. The composition includes stem cell-derived exosomes, an antioxidant, and a pH buffer. The patent also discusses the challenges of diagnosing and treating genitourinary syndrome of menopause (GSM) and the need for non-steroidal treatments for vaginal health issues. [Extracted from the article]

A recent report from Aix-Marseille University in Marseille, France, discusses the diagnostic strategies for bacterial vaginosis (BV), a common vaginal dysbiosis. The study evaluated different diagnostic methods, including a combination of abnormal vaginal discharge and pH, the Amsel-like criteria, the Nugent score, molecular quantification of specific bacteria, and MALDI-TOF mass spectrometry. The results showed that qPCR and "VAGI-TOF" provided consistent diagnoses of BV, followed by the Nugent score. The researchers suggest that "VAGI-TOF" could be a practical and cost-effective alternative to qPCR. [Extracted from the article]

A recent study conducted by researchers from Shahid Sadoughi University of Medical Sciences and Health Services in Yazd, Iran, has found that topical rose oil may be an effective treatment for cervicitis. Cervicitis is a common disease of the female reproductive system that can lead to various complications if left untreated. The study involved 80 married women with cervicitis who were randomly assigned to receive either rose oil or routine antimicrobial care. The results showed that both groups experienced improvements in symptoms such as burning, itching, vaginal discharge, and pain. The researchers concluded that rose oil could be used as an alternative treatment for cervicitis, especially in recurring cases. [Extracted from the article]

Keywords: Cancer; Cancer Screening; Cervical Screening; Colposcopy; Diagnostics and Screening; Gynecologic Surgery; Gynecologic Surgical Procedures; Gynecology; Health and Medicine; Obstetric Surgery; Obstetric Surgical Procedures; Obstetrics; Oncology; Surgery; Vaginal Discharge; Vaginal Diseases and Conditions; Women's Health EN Cancer Cancer Screening Cervical Screening Colposcopy Diagnostics and Screening Gynecologic Surgery Gynecologic Surgical Procedures Gynecology Health and Medicine Obstetric Surgery Obstetric Surgical Procedures Obstetrics Oncology Surgery Vaginal Discharge Vaginal Diseases and Conditions Women's Health 1200 1200 1 10/16/23 20231017 NES 231017 2023 OCT 17 (NewsRx) -- By a News Reporter-Staff News Editor at Women's Health Weekly -- New research on vaginal discharge is the subject of a new report. Cancer, Cancer Screening, Cervical Screening, Colposcopy, Diagnostics and Screening, Gynecologic Surgery, Gynecologic Surgical Procedures, Gynecology, Health and Medicine, Obstetric Surgery, Obstetric Surgical Procedures, Obstetrics, Oncology, Surgery, Vaginal Discharge, Vaginal Diseases and Conditions, Women's Health Colposcopy is a screening method that can be used to find precursor lesions for cancer. [Extracted from the article]

Keywords: Seoul; South Korea; Asia; Gynecology; Health and Medicine; Korea; OBGYN and Reproduction; Pediatrics; Women's Health EN Seoul South Korea Asia Gynecology Health and Medicine Korea OBGYN and Reproduction Pediatrics Women's Health 451 451 1 10/03/23 20231006 NES 231006 2023 OCT 7 (NewsRx) -- By a News Reporter-Staff News Editor at Pediatrics Week -- New research on OBGYN and Reproduction is the subject of a report. Keywords for this news article include: Seoul, Gynecology, Pediatrics, South Korea, Women's Health, Health and Medicine, OBGYN and Reproduction. Seoul, South Korea, Asia, Gynecology, Health and Medicine, Korea, OBGYN and Reproduction, Pediatrics, Women's Health. [Extracted from the article]

Keywords: Tianjin; People's Republic of China; Asia; Cancer; Carcinomas; Cervical Cancer; Diagnostics and Screening; Genetics; Gynecology; Health and Medicine; Oncology; Vaginal Discharge; Vaginal Diseases and Conditions; Women's Health EN Tianjin People's Republic of China Asia Cancer Carcinomas Cervical Cancer Diagnostics and Screening Genetics Gynecology Health and Medicine Oncology Vaginal Discharge Vaginal Diseases and Conditions Women's Health 953 953 1 08/14/23 20230815 NES 230815 2023 AUG 14 (NewsRx) -- By a News Reporter-Staff News Editor at Women's Health Weekly -- Research findings on Vaginal Diseases and Conditions - Vaginal Discharge are discussed in a new report. The accuracy were 92.7% and 89.3% in vaginal discharge and serum via certified by cervical carcinoma and benign cervical disease patient and healthy people.". [Extracted from the article]

Patent URL (for desktop use only): https://ppubs.uspto.gov/pubwebapp/external.html?q=(20230233139)&db=US-PGPUB&type=ids Keywords for this news article include: Genetics, Gynecology, Women's Health, Gastroenterology, Anal Incontinence, Fecal Incontinence, Patent Application, Health and Medicine, Urination Disorders, Urinary Incontinence, Pelvic Organ Prolapse, Female Urinary Tract Disorders, Rectal Diseases and Conditions, Urologic Diseases and Conditions. "In one aspect of the disclosure, a vaginal insert device for improving, managing, treating, preventing, and/or eliminating symptoms associated with pelvic organ prolapse, urinary incontinence, fecal incontinence, or combinations thereof, the vaginal insert device comprising: an upper portion having a cone-shaped body, a rim, and an upper end; a lower portion extending axially from the upper portion having a lower end; and a surface extending across the upper end such that the cone-shaped body is closed, wherein the rim is configured to apply pressure to an organ wall to improve, manage, treat, prevent, and/or eliminate symptoms associated with pelvic organ prolapse, urinary incontinence, fecal incontinence, or combinations thereof. Anal Incontinence, Digestive System Diseases and Conditions, Fecal Incontinence, Female Urinary Tract Disorders, Gastroenterology, Gastrointestinal Diseases and Conditions, Genetics, Gynecology, Health and Medicine, Patent Application, Pelvic Organ Prolapse, Rectal Diseases and Conditions, Urinary Incontinence, Urination Disorders, Urologic Diseases and Conditions, Women's Health. [Extracted from the article]

Candida, Candida albicans, Fungal Diseases and Conditions, Fungi, Gynecology, Health and Medicine, Public Health, Risk and Prevention, Vaginal Discharge, Vaginal Diseases and Conditions, Women's Health, Yeast Keywords: Candida; Candida albicans; Fungal Diseases and Conditions; Fungi; Gynecology; Health and Medicine; Public Health; Risk and Prevention; Vaginal Discharge; Vaginal Diseases and Conditions; Women's Health; Yeast EN Candida Candida albicans Fungal Diseases and Conditions Fungi Gynecology Health and Medicine Public Health Risk and Prevention Vaginal Discharge Vaginal Diseases and Conditions Women's Health Yeast 482 482 1 05/15/23 20230516 NES 230516 2023 MAY 18 (NewsRx) -- By a News Reporter-Staff News Editor at Women's Health Weekly -- New research on Candida albicans is the subject of a new report. [Extracted from the article]